Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06398158
Status:
RECRUITING
Last Update Posted:
2024-06-27
First Post:
2024-04-16
Brief Title:
Study of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum Disorder
Sponsor:
Organization:
University of Texas Southwestern Medical Center
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Whole blood samples will be routinely collected during the course of the study in addition to acute clinical relapses to assess the temporal course of change in serum neurofilament light chain glial fibrillary acidic protein tau and ubiquitin carboxyl-terminal hydrolase levels
Data captured from the samples collected may be utilized in the future to identify or verify putative prognostic and predictive markers associated with disease and markers of therapeutic response to treatment Baseline and dynamic within study clinical disease characteristics and associated biomarker data may be utilized to predict subsequent disease advancement along with severity identifying high-risk subgroups and identify predictors of response to treatment
Enrollment Count:
35
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 106620 |
Who Masked List: